ClinicalTrials.gg
CompletedNCT05062187Updated Feb 21, 2025

Lower Extremity Proprioception Sensory and Functionality in Hemiparetic

An observational study in Hemiparesis Proprioceptive Disorders Gait, Hemiplegic, Healthy Individual, Comparative Study, sponsored by Istanbul Aydın University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-21.

Sponsored by Istanbul Aydın University · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
60
Ages
20 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 18 studies in Paresis with a site in Turkey — 5 open to participants now, 5 under way, none of them phase 3. Paresis · Turkey.

Started
2021
with 1 other
Observational
4 of 18
none open now
Registered
6th of 18
by date
Lead sponsor
2 of 18
Istanbul Aydın University

Among the 18 studies in Paresis with a site in Turkey, this one is one of 2 that started in 2021, is one of 4 observational ones, and was the 6th registered.

Paresis

468 studies on the registry are indexed under Paresis; 117 are open to participants now.

This study's enrollment of 60 is above the median of 49 across 42 observational studies indexed under Paresis.

Browse Paresis studies →

Open to participants now

5 of the 18 studies in Paresis with a site in Turkey are open now, in 1 country. Each count lists the studies.

All 5 open studies →

Where they have run

Who these studies take

Of the 83 Paresis studies recruiting now, 34 (41%) set no upper age limit and 27 (33%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: 20 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Paresis with a site in Turkey, or all of them as a file.
02

Study summary

The loss of sensorial feedback causes gait impairment in hemiparesis. The studies show that proprioceptive impairment of knee is related to falling in these patients. The aim of this study is to investigate the effects of proprioception on balance and gait functions in hemiparetic individuals.

03

Conditions studied

  • Hemiparesis Proprioceptive Disorders Gait, Hemiplegic, Healthy Individual, Comparative Study
04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Hemiparetic individuals Healthy individuals

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 20-65 and discharged from the hospital,
  • Diagnosed with hemiparesis at least 4 weeks ago,
  • First time and unilateral hemiparesis,
  • Modified Rankin Score ≤ 3,
  • Hodkinson Mental Test ≥ 6,
  • Individuals who agree to receive treatment will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Having vision and hearing problems,
  • Having other accompanying neurological, psychiatric and/or orthopedic problems other than hemiparesis,
  • Medically unstable,
  • Diseases that will affect the lower extremity sense,
  • Individuals with open wounds, circulation problems, and skin lesions in the area to be treated will be excluded from the study.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • Proprioseption in hemiparetics

    Proprioception on balance and gait functions in hemiparetic individuals

    Other: Proprioseption in hemiparetics

  • Healthy Individual

    Proprioception on balance and gait functions in healthy individuals

    Other: Proprioseption in hemiparetics

Interventions

  • OtherProprioseption in hemiparetics

    Proprioception on balance and gait functions in hemiparetic individuals

06

What researchers measure

Primary outcomes

  1. Sensorial Assessment-1

    Semmes-Weinstein Monoflament

    Time frame: 2 minutes

  2. Sensorial Assessment-2

    Position test for lower extremity

    Time frame: 2 minutes

  3. Sensorial Assessment-3

    Kinestesia (Electrogoniometer)

    Time frame: 2 minutes

  4. Balance assessment

    Static balance via SportKAT-550

    Time frame: 30 second

  5. Gait parameters

    BTS G-Walk Spatiotemporal gait parameters

    Time frame: 1 minute

07

Study locations

1 site
  • Istanbul Aydın University
    Istanbul, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2021 to primary completion in Jun 2022, 7 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2021
First posted
Sep 30, 2021
StartActual
Nov 1, 2021
Primary completionActual
Jun 13, 2022
CompletionActual
Jul 13, 2022
Last update
Feb 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05062187
Lead sponsor
Istanbul Aydın University
Responsible party
Seref Duhan Altug (PT, Istanbul Aydın University) — Principal investigator
First posted
Sep 30, 2021
Start date
Nov 1, 2021
Primary completion
Jun 13, 2022
Completion
Jul 13, 2022
Last update
Feb 21, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion